Development of rapid light-chain deposition disease in hepatic arteries with severe ischemic cholangitis in a multiple myeloma patient treated with melphalan, prednisone and lenalidomide
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-01-15
著者
-
WEISEL Katja
Medical Center, Department of Hematology, Oncology and Immunology, University of Tubingen
-
BOCKELER Michael
Medical Center, Department of Hematology, Oncology and Immunology, University of Tubingen
-
BIANCHI Leonardo
Institute for Pathology
-
TERRACCIANO Luigi
Institute for Pathology
-
MAYER Frank
Medical Center, Department of Hematology, Oncology and Immunology, University of Tubingen
-
KANZ Lothar
Medical Center, Department of Hematology, Oncology and Immunology, University of Tubingen
-
Mayer Frank
Medical Center Department Of Hematology Oncology And Immunology University Of Tubingen
-
Kanz Lothar
Medical Center Department Of Hematology Oncology And Immunology University Of Tubingen
-
Weisel Katja
Medical Center Department Of Hematology Oncology And Immunology University Of Tubingen
-
Bockeler Michael
Medical Center Department Of Hematology Oncology And Immunology University Of Tubingen
関連論文
- Development of rapid light-chain deposition disease in hepatic arteries with severe ischemic cholangitis in a multiple myeloma patient treated with melphalan, prednisone and lenalidomide
- Oxidative stress and steatosis are cofactors of liver injury in primary biliary cirrhosis
- Langerhans cell histiocytosis of the stomach with atypical morphological features